Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
- PMID: 27959720
- DOI: 10.1056/NEJMc1612040
Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
Comment on
-
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.N Engl J Med. 2016 Aug 25;375(8):740-53. doi: 10.1056/NEJMoa1509277. Epub 2016 Jun 12. N Engl J Med. 2016. PMID: 27292104 Free PMC article. Clinical Trial.
-
Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia.N Engl J Med. 2016 Nov 24;375(21):2100. doi: 10.1056/NEJMc1612040. N Engl J Med. 2016. PMID: 27959721 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources